Background: Nail unit melanoma (NUM) is a rare variant of acral lentiginous melanoma. The differential diagnosis is wide but an acquired brown streak in the nail of a fair-skinned person must be considered a potential melanoma. Dermatoscopy helps clinicians to more accurately decide if a nail apparatus biopsy is necessary. Methods: We report the case of a 61-year-old Caucasian woman with melanonychia occupying the central portion of the right thumbnail plate with 1 year of evolution. Dermatoscopy showed a brown pigmentation overlaid by longitudinal irregular lines. An excisional biopsy was performed, and pathological examination revealed melanoma in situ. For safety reasons, the nail unit was totally removed down to the phalangeal bone 3 weeks later, and a full-thickness skin graft taken from the arm was used for reconstruction. Conclusion: NUMs pose a difficult treatment challenge. Wide excision with phalanx amputation is not satisfactory for patients with in situ and early invasive melanoma. Full-thickness skin grafting after total nail unit excision is a simple procedure providing a good functional and cosmetic outcome.

1.
Haneke E: Nail surgery; in Rusciani L, Robins P (eds): Textbook of Dermatologic Surgery. Padova, Piccin Nuova Libraria, 2008, vol I, pp 293–311.
2.
Eedy DJ: Surgical treatment of melanoma. Br J Dermatol 2003;149:2–12.
3.
Phan A, Touzet S, Dalle S, Ronger-Savle S, Balme B, Thomas L: Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 2006;155:561–569.
4.
High WA, Quirey RA, Guillén DR, et al: Presentation, histopathologic findings, and clinical outcomes in 7 cases of melanoma in situ of the nail unit. Arch Dermatol 2004;140:1102–1106.
5.
Baran R, Barth J, Dawber R: Periungual tissue disorders; in Baran R, Barth J, Dawber R (eds): Nail Disorders: Common Presenting Signs, Differential Diagnosis and Treatment. London, Dunitz, 1991, pp 123–126.
6.
Haneke E, Binder D: Subunguales Melanom mit streifiger Nagelpigmentierung. Hautarzt 1978;29:389–391.
7.
Braun RP, Baran R, Le Gal FA, et al: Diagnosis and management of nail pigmentations. J Am Acad Dermatol 2007;56:835–847.
8.
Phan A, Touzet S, Dalle S, Ronger-Savle S, Balme B, Thomas L: Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol 2007;157:311–318.
9.
Haneke E, Baran R: Longitudinal melanonychia. Dermatol Surg 2001;27:580–584.
10.
Moehrle M, Metzger S, Schippert W, Garbe C, Rassner G, Breuninger H: ‘Functional’ surgery in subungual melanoma. Dermatol Surg 2003;29:366–374.
11.
Haneke E: Clinical judgement: a lesson derived from a subungual melanoma. Dermatopathol Pract Concept 2000;6:73–76.
12.
Haneke E: Melanoma of the nail organ – diagnosis, differential diagnosis and treatment options. Dermatol Esthet 2008;10:223–228.
13.
Lazar A, Abimelec P, Dumontier C: Full thickness skin graft for nail unit reconstruction. J Hand Surg 2005;30:194–198.
14.
Haneke E: Operative Therapie akraler und subungualer Melanome; in Rompel R, Petres J (eds): Operative und onkologische Dermatologie. Fortschritte der operativen und onkologischen Dermatologie. Berlin, Springer, 1999, vol 15, pp 210–214.
15.
Ronger S, Touzet S, Ligeron C, et al: Dermoscopic examination of nail pigmentation. Arch Dermatol 2002;138:1369–1370.
16.
Thomas L, Dalle S: Dermoscopy provides useful information for the management of melanonychia striata. Dermatol Ther 2007;20:3–10.
17.
Hirata SH, Yamada S, Almeida FA, et al: Dermoscopic examination of the nail bed and matrix. Int J Dermatol2006;45:28–30.
18.
Wagner A, Garrido I, Ferron G, et al: Subungual melanoma: for a conservative approach on the thumb scale. Ann Plast Surg 2007;59:344–348.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.